HeberFERON in Treating Basosquamous Carcinoma

Authors

Keywords:

HeberFERON, interferons, basal squamous carcinoma, metatypic carcinoma.

Abstract

Introduction: Basal squamous cell carcinoma is an aggressive subtype of basal cell carcinoma composed of basaloid cells and areas of squamous cells with an intermediate transition zone, with a tendency to recur and metastasize.

Objective: To describe the clinical case of a patient with a basal squamous cell carcinoma in the temporal region near the external canthus of the left eye.

Case report: This paper reports a case of a female patient with a basal squamous cell carcinoma in the temporal region near the external canthus of her left eye with 30 mm diameter. HeberFERON was used with complete response when eliminating the tumor.

Conclusions: HeberFERON is a non-surgical treatment option that can be used in facial basal squamous cell carcinoma that, due to its size, can cause mutilations or deformities in this area.

 

 

Downloads

Author Biographies

Vladimir Sánchez, Policlínico Centro

Médico

Olivia María Tamayo Pérez, Médico

Medico

Elizabeth Brito Garcia, Pol centro

Medico

Iraldo Bello Rivero, CIGB La Habana

Doctor en Ciencias

Egduina Rondón Madrigal, Hospital Provincial Camilo Cienfuegos

Dictora en ciencias

Published

2023-08-28

How to Cite

1.
Sánchez V, Tamayo Pérez OM, Brito Garcia E, Bello Rivero I, Rondón Madrigal E. HeberFERON in Treating Basosquamous Carcinoma. Rev Cubana Med [Internet]. 2023 Aug. 28 [cited 2025 Jul. 8];62(3). Available from: https://revmedicina.sld.cu/index.php/med/article/view/3178